アクセス数 : ?
ダウンロード数 : ?
ID 115283
著者
板東, 浩 Tokushima University|Sakamoto Hospital KAKEN研究者をさがす
Iwatsuki, Noboru Sakamoto Hospital
Sakamoto, Kazuki Sakamoto Hospital
Ogawa, Tomoya Sakamoto Hospital
キーワード
American diabetes association
estimated glomerular filtration rate
atherosclerotic cardiovascular disease
chronic kidney disease
diabetic kidney disease
資料タイプ
学術雑誌論文
抄録
Diabetes has been a prevalent disease worldwide, and metformin has been used widely as an oral hypoglycemic agent (OHA) for type 2 diabetes mellitus (T2DM). Its benefits include low cost, weight neutrality, general effect and positive efficacy for cardiovascular system. American Diabetes Association (ADA) has proposed diabetic guidelines-2020 and evaluated metformin as predominant agent. They include i) the preferred initial pharmacologic agent for T2DM, ii) once starting of metformin, it should be continued as long as tolerated without contraindication. Furthermore, recent studies showed safer effect for impaired renal function. We cannot exclude such results and will contribute the prevention of atherosclerotic cardiovascular disease (ASCVD).
掲載誌名
Journal of Clinical Case Reports and Medical Research
出版者
Ciencia Scientific Publisher
1
1
開始ページ
JCCRMR-20-05
発行日
2020-07-14
権利情報
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license(https://creativecommons.org/licenses/by/4.0/)
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
医学系